How to measure comorbidity. a critical review of available methods.

By V. de Groot, H. Beckerman, G. Lankhorst, Lex M. Bouter. Journal of Clinical Epidemiology, 2003

1,862 citations recorded by the source corpus.

Subfields: Economics and Econometrics, Epidemiology, Geriatrics and Gerontology

View Paper: https://www.semanticscholar.org/paper/9a37cd7ef37c3d30b2445f9dd42006b82793ec6d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Economics and Econometrics

1. Lars Juhl Jensen
2. Søren Brunak

Citations in the corpus

• Mining electronic health records: towards better research applications and clinical care (2012, background): “In clinical practice, the cumulated disease burden of a patient is often summarized in comorbidity scores such as the Charlson index , and these scores are also often used to interpret confounding effects of comorbid diseases in cohort studies 38 .”
• Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. (2008, neutral): “001 Parathyroid hormone level, median (IQR), pg/mL 34 (26-46) 30 (23-40) 28 (21-36) 25 (19-33) .”
• Multimorbidity (2022, methodology): “Chan School of Public Health (BLSCHP-1902), Bloomberg Philanthropies (via University of North Carolina at Chapel Hill School of Public Health), FONDECYT via CIENCIACTIVA/CONCYTEC, British Council, British Embassy and the NewtonPaulet Fund (223-2018, 224-2018), DFID/ MRC/Wellcome Global Health Trials”
• An electronic application for rapidly calculating Charlson comorbidity score (2004, methodology): “For more detailed reviews of the comorbidity indices outlined in this article, the authors refer readers to three systematic reviews of comorbid illness scoring systems by Extermann and de Groot [2-4].”
• The measurement of multiple chronic diseases--a systematic review on existing multimorbidity indices. (2011, background): “Accordingly, there is no agreement on the number and type of diseases to be included in multimorbidity indices (5).”